US panel replaced under Trump backs new shot for kids
Clesrovimab was recently approved by the Food and Drug Administration as a shot for newborns and young babies experiencing their first respiratory syncytial virus (RSV) season.
Marketed under the name Enflonsia by its manufacturer Merck, it was shown in clinical trials to be safe and effective at significantly reducing RSV infections and hospitalizations among infants.
The ACIP panel was asked to adjudicate the next step after approval -- namely, whether it should now be recommended for infants under eight months old entering their first RSV season who are not already protected by an RSV vaccine administered to their mother during pregnancy.
They voted 5-2 in favor.
The two dissenters were Retsef Levi, a professor of operations management at MIT who has questioned the safety of Covid-19 vaccines, and Vicky Pebsworth, a nurse and member of the anti-vaccine National Vaccine Information Center (NVIC).
"I don't feel this is ready to be administered to all healthy babies. I think we should take a more precautionary approach," said Levi, explaining his "no" vote.
Pebsworth did not offer comments, but the NVIC previously opposed the earlier-approved RSV antibody, nirsevimab.
Kennedy -- who spent decades spreading vaccine misinformation before becoming President Donald Trump's top health official -- abruptly fired all 17 members of the ACIP earlier this month, accusing them of conflicts of interest.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
LeMonde
5 days ago
- LeMonde
'The decline in vaccine coverage in the US can and will have global consequences'
For decades, vaccination has been one of the main pillars of public health in the United States. This pillar has particularly relied on the expertise of the Advisory Committee on Immunization Practices (ACIP) established in 1964. Its mission has been to provide independent recommendations for vaccine use based on the best available scientific evidence. The committee has contributed to the gradual integration of available vaccines into a harmonized vaccination schedule, which is updated every year. Thanks to regular nationwide campaigns, the country managed to eliminate or control once-feared diseases such as measles, whooping cough, polio and diphtheria, which had previously caused a high number of deaths or disabilities each year. For instance, there were nearly 13 deaths for every 100,000 inhabitants in 1919. The rate fell to zero with the implementation of widespread population vaccination. While scientific evidence demonstrating the effectiveness and safety of vaccines has never been stronger, some diseases have resurfaced. Measles, which had been declared eliminated from the US in 2000, has returned at worrying levels, with more than 1,000 cases reported in 2025. Reduced vaccine coverage is the culprit. In April, the Journal of the American Medical Association published a study projecting that a 10% drop in measles vaccine coverage could result in more than 11 million additional cases in the US over the next 25 years. Whooping cough, long under control, is experiencing a troubling resurgence. Other threats are looming, such as the potential re-emergence of polio, whose near eradication had been viewed as a major victory for modern medicine. What is happening in the US is an intensified version of the situation in many countries, including France. The Covid-19 pandemic highlighted widespread distrust among many citizens toward health authorities, experts and, more broadly, vaccines. The rapid development of mRNA vaccines, the sometimes contradictory messages from experts and the politicization of certain public health measures have all fostered a lasting climate of suspicion.
Euronews
5 days ago
- Euronews
EU keeps racing pigeons tethered as bird flu ruffles feathers
The European Commission has clarified that it's not planning to loosen animal health rules for pigeons soon, despite calls from lawmakers and pigeon fanciers to go easier on the birds. Liberal MEP Hilde Vautmans, from Belgium – where pigeon racing is very popular – asked the Commission in a written parliamentary question whether it would revise EU rules along species specific lines, which might benefit pigeons. She argued that scientific evidence shows racing pigeons are not the main culprits when it comes to spreading highly pathogenic avian influenza virus (HPAIV), and yet they're treated as if they might be plotting to spread a bird flu pandemic. Under current EU law, pigeons are regulated in the same way as other captive birds such as poultry and parrots. This means pigeon keepers must follow strict biosecurity measures, including disinfected perches, limited outdoor freedom, and loft lockdowns—redolent of restrictions placed on humans during the COVID-19 pandemic. By contrast, wild birds are left free since they are not under human control, despite the fact that they also carry avian flu. Vautmans argues that's unfair. She says the law doesn't reflect the reality that not all birds are equal in their disease-spreading risks. And while bird flu is now worryingly common in wild species, the science still points to pigeons being relatively low-risk. In his response on Tuesday, animal welfare Commissioner Olivér Várhelyi didn't slam the loft door shut on future changes but made it clear that rule tweaks need solid data and can't risk the broader animal health system. The Commissioner also pointed to growing scientific concerns. 'Recent literature indicates that HPAI viruses may circulate in pigeons at an underestimated intensity, and they could act as an interspecies bridge in the ecology of virus transmission,' he wrote. So for now, the rules stay put, with changes to the EU rules could be considered, but only if backed by robust scientific evidence and without compromising animal health across the EU. Vautmans also requested specific exemptions for pigeon racing, a practice the sector claims poses minimal risk of disease spread and which it wants recognised for its genetic and cultural significance. Racing pigeons are elite athletes of the bird world, bred over generations for speed, stamina, and GPS-like homing skills. Races see them taken far from home and timed on how fast they can fly back. It's like the Tour de France, but with feathers and fewer spandex shorts. The Commissioner, however, pointed out that racing pigeons already enjoy a few perks. They can cross EU borders without a veterinary passport and even enter from third countries, provided they don't loiter and are released to fly home immediately. Member states can also grant further exemptions during outbreaks, if they deem it safe. In short, the Commission believes the current setup gives racing pigeons enough wiggle room, and it is not planning any new exemptions. So while pigeon racers may feel cooped up under current rules, the EU isn't budging yet. Until the science says otherwise, it's safety first, even if that means keeping some very fast birds on a short leash.
Euronews
30-06-2025
- Euronews
We may never know for sure how COVID-19 began, WHO says
Scientists still aren't sure how the COVID-19 pandemic – the worst health emergency in a century – began. That was the unsatisfying conclusion from an expert group charged by the World Health Organization (WHO) to investigate the pandemic's origins in its final report. Marietjie Venter, the group's chair, said at a press briefing that most scientific data supports the hypothesis that the new coronavirus jumped to humans from animals. That was also the conclusion drawn by the first WHO expert group that investigated the pandemic's origins in 2021, when scientists concluded the virus likely spread from bats to humans, via another intermediary animal. At the time, WHO said a lab leak was 'extremely unlikely'. Venter said that after more than three years of work, WHO's expert group was unable to get the necessary data to evaluate whether or not COVID-19 was the result of a lab accident, despite repeated requests for hundreds of genetic sequences and more detailed biosecurity information that were made to the Chinese government. 'Therefore, this hypothesis could not be investigated or excluded,' she said. 'It was deemed to be very speculative, based on political opinions and not backed up by science'. She said that the 27-member group did not reach a consensus; one member resigned earlier this week and three others asked for their names to be removed from the report. Venter said there was no evidence to prove that COVID-19 had been manipulated in a lab, nor was there any indication that the virus had been spreading before December 2019 anywhere outside of China. 'Until more scientific data becomes available, the origins of how SARS-CoV-2 entered human populations will remain inconclusive,' Venter said, referring to the scientific name for the COVID-19 virus. WHO Director-General Tedros Adhanom Ghebreyesus said it was a 'moral imperative' to determine how COVID began, noting that the virus killed at least 20 million people, wiped at least $10 trillion (€8.8 trillion) from the global economy and upended the lives of billions of people. Last year, the AP found that the Chinese government froze meaningful domestic and international efforts to trace the virus' origins in the first weeks of the outbreak in 2020 and that WHO itself may have missed early opportunities to investigate how COVID-19 began. US President Donald Trump has long blamed the emergence of the coronavirus on a laboratory accident in China, while a US intelligence analysis found there was insufficient evidence to prove the theory. Chinese officials have repeatedly dismissed the idea that the pandemic could have started in a lab, saying that the search for its origins should be conducted in other countries. Last September, researchers zeroed in on a short list of animals they think might have spread COVID-19 to humans, including racoon dogs, civet cats, and bamboo rats.
